The TP-25 tray packer for aseptic cartons from Schneider Packaging Equipment (Brewerton, NY) runs 1-L aseptic cartons at up to 25 trays/min. A positive product handling/laning system allows for pre-collation of product and acts as an in-process accumulator.
Nestlé Friskies Italia is the first globally to use a retortable carton from Tetra Pak (Vernon Hills, IL). Commercialized in May for its new Friskies “Qualità Freschezza” petfood, the Tetra Recart™ technology is more than two years from a U.S.
Caprice des Dieux is a popular cheese brand in France immediately recognized by its oval-shaped, blue paperboard carton. So when French cheese marketer Bressor launched a brand extension called Caprice des Anges, it was essential that the new product’s packaging build on the equity already established by its Caprice des Dieux.
Golden, CO-based EAS has a new ready-to-drink shake, AdvantEdge, on store shelves in an octagonal-shaped 11-oz Tetra Prisma aseptic carton. For the company’s first single-serve nutritional beverage, EAS conducted research to provide its customers with a convenient drink box.
Using saturated steam instead of chemicals to thermoform, fill, and seal aseptic packages, TAS fillers from Hassia (Morganville, NJ) offer a maximum forming depth of 110 mm (4.334”) and accept a maximum web width of 80 cm (31.496”).
Ukrainian importers of the Smirnoff brand of vodka overcame counterfeit sales this spring by adding a clear polyvinyl chloride neck shrink sleeve that features an optically variable device (OVD) to ensure product brand identity.
What was once reviled by environmentalists in the United States and was actually banned in the state of Maine in the early ‘90s is now the recipient of an environmental award in Canada. A new 250-ml recyclable Tetra® Prisma aseptic carton, which holds Oasis Health Break juice cocktails from A. Lassonde, Montreal, Quebec, Canada, received an Envirowise Award for its recyclability from the Packaging Association of Canada in April ’01.
In December, Peapack, NJ-based Pharmacia Corp. received Food and Drug Administration approval to produce its parenteral drug Caverject on an aseptic filling system that improves sterility assurance before and during vial filling, checkweighing and stoppering processes.